Glyscend, Inc.
🇺🇸United States
Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)A 16-Week Study to Evaluate the Efficacy, Safety, and Tolerability of GLY-200 in Participants With Obesity
- First Posted Date
- 2024-02-14
- Last Posted Date
- 2025-01-23
- Lead Sponsor
- Glyscend, Inc.
- Target Recruit Count
- 75
- Registration Number
- NCT06259981
- Locations
- 🇺🇸
Tampa Bay Medical Research, Inc., Clearwater, Florida, United States
🇺🇸Sensible Healthcare, LLC, Ocoee, Florida, United States
🇺🇸Tandem Clinical Research, Marrero, Louisiana, United States
A Study Evaluating the Safety, Tolerability, and Pharmacodynamic Effects of GLY-200 in Type 2 Diabetic Patients
- First Posted Date
- 2022-07-28
- Last Posted Date
- 2025-02-10
- Lead Sponsor
- Glyscend, Inc.
- Target Recruit Count
- 51
- Registration Number
- NCT05478525
- Locations
- 🇺🇸
ProSciento, Inc., Chula Vista, California, United States
News
No news found